Article Details

Morgan Stanley cuts Cytokinetics to equal weight but raises price target (NASDAQ:CYTK)

Retrieved on: 2024-01-05 20:47:27

Tags for this article:

Click the tags to see associated articles and topics

Morgan Stanley cuts Cytokinetics to equal weight but raises price target (NASDAQ:CYTK). View article details on hiswai:

Excerpt

Morgan Stanley downgraded Cytokinetics (CYTK) to equal weight but raised its price target, stating the shares were reaching full valuation.

Article found on: seekingalpha.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo